
Solara Active Pharma Sciences Limited has informed the Exchange regarding a press release dated May 20, 2024, titled "USFDA concludes inspection at Solara s Visakhapatnam Facility with Zero 483 inspectional observations.".
Filed with NSE ·

Solara Active Pharma Sciences Limited has informed the Exchange regarding a press release dated May 20, 2024, titled "USFDA concludes inspection at Solara s Visakhapatnam Facility with Zero 483 inspectional observations.".
6ix hasn’t read this filing yet.
Solara Active Pharma Sciences Ltd. on 6ix
Follow Solara Active Pharma Sciences into a list and get an email when it puts out news.
Follow Solara Active Pharma Sciences